Bryn Mawr Trust CO Dynavax Technologies Corp Transaction History
Bryn Mawr Trust CO
- $5.44 Billion
- Q4 2024
A detailed history of Bryn Mawr Trust CO transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Bryn Mawr Trust CO holds 8,000 shares of DVAX stock, worth $108,640. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,000
Previous 8,000
-0.0%
Holding current value
$108,640
Previous $89,000
14.61%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding DVAX
# of Institutions
288Shares Held
131MCall Options Held
507KPut Options Held
374K-
Black Rock Inc. New York, NY21.9MShares$297 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT17.8MShares$242 Million10.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$124 Million0.0% of portfolio
-
State Street Corp Boston, MA7.79MShares$106 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ6.56MShares$89.1 Million5.31% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.72B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...